Drug Shortage Report for BREVICON 0.5/35 TABLETS (28-DAY PACK)
Report ID | 119176 |
Drug Identification Number | 02187094 |
Brand name | BREVICON 0.5/35 TABLETS (28-DAY PACK) |
Common or Proper name | BREVICON 28 |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | ETHINYL ESTRADIOL NORETHINDRONE |
Strength(s) | .035MG .5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 28's |
ATC code | G03AA |
ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-06-29 |
Estimated end date | 2021-02-22 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-01-15 |
Company comments | Recovery expected during Feb 2021. |
Health Canada comments | |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.